Evidence map›Paper›PMID 40042738›Full record

Trial reportDrug delivery and translational research2025

Micropore visualization and lifetime following microneedle application to skin of differing pigments.

Valeria Cota, Nicole K Brogden

Registry-linked trialAbstract readClinical Trial
In one paragraph

Trial report in Drug delivery and translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04867733 (Evaluating Racial and Ethnic Differences in Dermal Micropore Formation Using Optical Coherence Tomography), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04867733 nacompletednot on this map

Evaluating Racial and Ethnic Differences in Dermal Micropore Formation Using Optical Coherence Tomography

TypeinterventionalSponsorUniversity of IowaRan2021 to 2022Enrolled49ConditionsHealthyArmsMicropatch (microneedle patch)
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Valeria CotaDepartment of Pharmaceutical Sciences and Experimental Therapeutics, The University of Iowa College of Pharmacy, Iowa City, IA, 52242, USA.ORCID 0000-0003-1019-3400
Nicole K BrogdenDepartment of Pharmaceutical Sciences and Experimental Therapeutics, The University of Iowa College of Pharmacy, Iowa City, IA, 52242, USA. nicole-brogden@uiowa.edu.ORCID 0000-0001-6838-8847

Funding

The effects of pharmacologic and physiologic variables on the pharmacokinetics of microneedle drug deliveryR35GM124551 · NIGMS · UNIVERSITY OF IOWA · PI BROGDEN, NICOLE K · 2017 to 2021
$2.1M
A translational approach to predicting small molecule drug permeation through microneedle-treated skinR35GM149337 · NIGMS · UNIVERSITY OF IOWA · PI Nicole K. Brogden · 2023 to 2026
$1.6M
Mechanisms of micropore closure after microneedle application in diverse skin typesF31AR081680 · NIAMS · UNIVERSITY OF IOWA · PI COTA, VALERIA · 2023 to 2025
$100k
NIAMS NIH HHS F31 AR081680NIGMS NIH HHS R35 GM124551NIGMS NIH HHS R35 GM149337NIH HHS F31AR081680NIH HHS R35GM124551NIH HHS R35GM149337
6 · The paper itself

Abstract

Solid microneedles allow dermal delivery of drugs that cannot otherwise absorb through skin, via creation of epidermal micropores. The time that the micropores remain open (micropore lifetime) directly impacts drug delivery windows, and darker skin types have extended micropore lifetimes. Here we visualized dermal micropores and measured micropore lifetime in subjects with differing skin pigmentation (ClinicalTrials.gov identifier NCT04867733, registered 29th April 2021). Forty-nine subjects completed the study, self-identifying as Asian, Black, Caucasian, Latinx, and Bi-/multi-racial. Using a colorimeter, skin color was objectively measured and subjects were grouped according to dark (n = 13), medium (n = 19), or light (n = 17) skin. Stainless steel microneedles, 800 μm length, were applied to the arm. Impedance measurements confirmed a breach of skin barrier, suggesting adequate micropore formation. Micropore depth immediately post-microneedle application ranged from 70.3 to 106.6 μm across all subjects (n = 98 total measurements), but was not different between skin color groups, P > 0.05. OCT images were used to calculate micropore closure over 48 h. At 24 h there was no difference in % change in micropore depth between groups. By 48 h there was an 18.1% difference in micropore closure between the lightest and darkest skinned groups, P < 0.05. These data were in agreement with impedance-predicted micropore lifetimes. The longer micropore lifetime in darker skin was independent of micropore depth, and future mechanistic studies of physiological processes underlying these observations would contribute to an understudied area in skin of color research. Proof of concept pharmacokinetics studies would also be useful to investigate the full impact of these differences.

Indexed as

Drug Delivery SystemsNeedlesSkinSkin PigmentationAdministration, CutaneousAdultFemaleHumansMaleMicroinjectionsMiddle AgedSkin AbsorptionTomography, Optical CoherenceYoung AdultDiversityDrug deliveryMicroneedleOptical coherence tomographySkin of colorTransdermal

Identifiers

PMID40042738
PMCPMC12353774

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.